Outcome of COVID-19-Associated Rhino-Orbital Mucormycosis

JAMA Ophthalmol. 2022 May 1;140(5):548. doi: 10.1001/jamaophthalmol.2022.0618.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antifungal Agents / therapeutic use
  • COVID-19*
  • Eye Diseases* / drug therapy
  • Eye Infections, Fungal* / diagnosis
  • Eye Infections, Fungal* / drug therapy
  • Humans
  • Mucormycosis* / diagnosis
  • Mucormycosis* / drug therapy
  • Orbital Diseases* / diagnosis
  • Orbital Diseases* / drug therapy
  • SARS-CoV-2

Substances

  • Antifungal Agents